Effect of HIV protease inhibitors and Orlistat on mycobacterial ES-31 serine protease, a potential drug target in Mycobacterium tuberculosis

Indian Journal of Tuberculosis

Volumn 58, Issue 1, 2011, Pages 4-10

  Majumdar, Anindita ^a   Wankhade, Gauri ^a   Kamble, Pranita D ^a   Harinath, B C ^a  

^a MAHATMA GANDHI INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

HIV; Lopinavir; Mycobacterial ES 31 serine protease; Mycobacterium tuberculosis; Orlistat; Ritonavir

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR; INDINAVIR; LOPINAVIR; MYCOBACTERIUM ANTIGEN; MYCOBACTERIUM EXCRETORY SECRETORY 31 ANTIGEN; PHOSPHOLIPASE INHIBITOR; RITONAVIR; SERINE PROTEINASE; TETRAHYDROLIPSTATIN; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; COLONY FORMING UNIT S; CONTROLLED STUDY; DRUG DETERMINATION; DRUG EFFECT; DRUG TARGETING; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GROWTH INHIBITION; IN VITRO STUDY; NONHUMAN; STOMACH SECRETION; TUBERCULOSIS;

ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HIV PROTEASE INHIBITORS; HUMANS; LACTONES; MYCOBACTERIUM TUBERCULOSIS; PYRIMIDINONES; RITONAVIR; SERINE ENDOPEPTIDASES; TUBERCULOSIS;

EID: 79955513263     PISSN: 00195707     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Maeda H. Role of microbial proteases in pathogenesis. Microbiol Immunol 1996; 40: 685-699.
2. Brown GD, Dave JA, Gey van Pittius NC, Stevens L, Ehlers MRW, Beyers AD. The mycosins of Mycobacterium tuberculosis H37Rv: a family of subtilisin-like serine proteases. Gene 2000; 254: 147-155.
3. Dave JA, Pittius NCG, Beyers AD, Ehlers MRW and Brown GD. Mycosin-1, a subtilisin-like serine protease of Mycobacterium tuberculosis, is cell wall-associated and expressed during infection of macrophages. BMC Microbiol 2002; 2: 1-8.
4. Nair ER, Banerjee S, Gupta S, Kumar S, Reddy MVR, Harinath BC. Seroreactivity and characterization of 31 kDa M.tb. secretory protease of diagnostic interest in tuberculosis. Trends Clin Biochem Lab Med 2003; 330-338.
5. Shende N, Gupta S, Bhatia AS, Kumar S, Harinath BC. Detection of free and immune complexed serine protease and its antibody in patients of tuberculosis with and without HIV co-infection. Int J Tuberc Lung Dis 2005; 9(8): 915-919.
6. Upadhye V, Gomashe A, Kumar S, Harinath BC. Isolation, characterization and kinetic studies on SEVA TB ES-31 antigen, a metalloserine protease of interest in diagnosis. Indian J Tuberc 2009; 56: 22-29.
7. G Wankhade, A Majumdar, P Kamble, BC Harinath. Mycobacterial SEVATB ES-31 antigen with catalytic activities of serine protease and lipase with drug target potential. In communication.
8. Upadhye V, Majumdar A, Gomashe A, Joshi D, Gangane N, Thamke D. Mendiratta D, Harinath BC. Inhibition of Mycobacterium tuberculosis secretory serine protease blocks bacterial multiplication both in axenic culture and in human macrophages. Scand J Infect Dis 2009; 41(8): 569-576.
9. World Health Organization. Strategic framework to decrease the burden of TB/HIV. WHO/CDS/TB/ 2002.296, WHO/HIV_AIDS/2002.2)
10. Brik A, Wong CH. HIV-1 protease: mechanism and drug discovery. Org Biomol Chem 2003; 1 (1): 5-14.
11. Wood AJJ. HIV-protease inhibitors. New Eng J Med 1998: 338 (18): 1281-1292.
12. Pramanik J, Lodam AN, Reddy MVR, Narang P and Harinath BC. Increased yield of excretory secretory antigen with thyroxine supplement in in vitro culture of tubercle bacilli. Indian J Tuberc 1997; 44:185-190.
13. Nair ER, Banerjee S, Kumar S, Reddy MVR and Harinath BC. Purification and characterization of a 31kDa mycobacterial excretory - secretory antigenic protein with a diagnostic potential in pulmonary tuberculosis. Ind J Chest Dis Allied Sci 2001; 43: 81-90.
14. Harinath BC, Kumar S, Saha-Roy S, Hirudkar S, Upadhye V, Shende N. A cocktail of affinity-purified antibodies reactive with diagnostically useful mycobacterial antigens ES-31, ES-43 and EST-6 for detecting the presence of Mycobacterium tuberculosis. Diagn Microbiol Infect Dis 2006; 55: 65-69.
15. Nair ER, Banerjee S, Kumar S, Reddy MVR, Harinath BC. Isolation of Mycobacterium tuberculosis 31 kDa antigen protein of diagnostic interest from culture filtrate using anti ES-31 antibody by affinity chromatography. Indian J Clin Biochem 2001; 16: 132-135.
16. Majumdar A, Upadhye V, Harinath BC. Peroxidase enzyme immunoassay for circulating SEVA TB ES-31 Antigen in pulmonary tuberculosis sera. Biomed Res 2008; 19(3): 201-206.
17. Laal S, Samanich KM, Sonnenberg MG, Zolla-Pazner S, Phadtare JM and Belisle JT. Human humoral responses to antigens of Mycobacterium tuberculosis: immunodominance of high-molecular-mass antigens. Clin Diagn Lab Immunol 1997; 4: 49-56.
18. Belisle JT, Vissa VD, Sievert K, Takayama K, Brennan P and Besra GS. Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis. Science 1997; 276: 1420-1422.
19. Nair ER, Banerjee S, Kumar S and Harinath BC. Isolation and characterization of a 31 kDa mycobacterial antigen from tuberculous sera and its identification with in vitro released culture filtrate antigen of M. tb. H37Ra bacilli. Scand J Infect Dis 2000; 32: 551-556.
20. Harth G, Horwitz MA. An inhibitor of exported Mycobacterium tuberculosis Glutamine Synthetase selectively blocks the growth of pathogenic mycobacteria in axenic culture and in human monocytes: extracellular proteins as potential novel drug targets. J Exp Med 1999; 189: 1425-1435.
21. Suwailem AK, Tamimi AS, Omer MA, Suhabani MS. Safety and mechanism of action of Orlistat (Tetrahydrolipstatin) as the first local antiobesity drug. J App Sci Res 2006; 2(4): 205-208.